Related Experiment Video
Updated: Jan 23, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.9K
Progress in research on paclitaxel and tumor immunotherapy
1College of Biological Science and Engineering, Fuzhou University, Fuzhou, 350108 China.
Cellular & Molecular Biology Letters
|June 22, 2019
Summary
Paclitaxel, a natural anticancer drug, shows promise in tumor immunity. Advances in biotechnology have significantly increased paclitaxel yields, enhancing its potential for cancer treatments.
Area of Science:
- Natural product chemistry
- Pharmacology
- Biotechnology
Background:
- Paclitaxel is a highly successful natural anticancer agent.
- Its unique mechanism of action has been extensively studied.
- Natural sources and biosynthesis are key areas of research.
Purpose of the Study:
- To summarize recent advances in paclitaxel research.
- To explore sources, anticancer mechanisms, and biosynthesis.
- To highlight the role of paclitaxel in tumor immunity and its therapeutic potential.
Main Methods:
- Review of recent scientific literature.
- Analysis of advancements in biotechnology for yield improvement.
- Investigation of paclitaxel's role in cancer immunology.
Main Results:
- Significant increases in paclitaxel yield through biotechnological improvements.
- Enhanced understanding of paclitaxel's anticancer mechanisms.
- Emerging evidence of paclitaxel's impact on tumor immunity.
Conclusions:
- Biotechnology has greatly improved paclitaxel production.
- Paclitaxel demonstrates significant potential in cancer treatment, particularly through its role in tumor immunity.
Related Concept Videos
01:27Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
02:07Tumor Progression
7.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.3K
03:03mTOR Signaling and Cancer Progression
4.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.7K
02:17The Tumor Microenvironment
7.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.7K
02:40Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K